301 related articles for article (PubMed ID: 27422988)
21. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
22. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat.
Hodge G; Ye VZ; Duggan KA
Exp Physiol; 2002 Jan; 87(1):1-8. PubMed ID: 11805851
[TBL] [Abstract][Full Text] [Related]
23. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
24. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
Goto K; Fujii K; Kansui Y; Iida M
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
[TBL] [Abstract][Full Text] [Related]
25. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
Lee BH; Shin HS
Jpn J Pharmacol; 1997 May; 74(1):83-90. PubMed ID: 9195301
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide inhibition and renal alterations.
Jover B; Mimran A
J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S65-70. PubMed ID: 11811381
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries.
Itoh T; Kajikuri J; Tada T; Suzuki Y; Mabuchi Y
J Physiol; 2003 May; 548(Pt 3):893-906. PubMed ID: 12651915
[TBL] [Abstract][Full Text] [Related]
28. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
[TBL] [Abstract][Full Text] [Related]
29. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
30. Impaired activity of adherens junctions contributes to endothelial dilator dysfunction in ageing rat arteries.
Chang F; Flavahan S; Flavahan NA
J Physiol; 2017 Aug; 595(15):5143-5158. PubMed ID: 28561330
[TBL] [Abstract][Full Text] [Related]
31. Blockade of AT1 receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats.
Zhang R; Bai YG; Lin LJ; Bao JX; Zhang YY; Tang H; Cheng JH; Jia GL; Ren XL; Ma J
J Appl Physiol (1985); 2009 Jan; 106(1):251-8. PubMed ID: 18988766
[TBL] [Abstract][Full Text] [Related]
32. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Nasser SA; Sabra R; Elmallah AI; El-Din MM; Khedr MM; El-Mas MM
Life Sci; 2016 Oct; 163():1-10. PubMed ID: 27575704
[TBL] [Abstract][Full Text] [Related]
33. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
[TBL] [Abstract][Full Text] [Related]
35. Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats.
Siddiqui AH; Hussain T
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1722-7. PubMed ID: 17142345
[TBL] [Abstract][Full Text] [Related]
36. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
Sueta D; Koibuchi N; Hasegawa Y; Toyama K; Uekawa K; Katayama T; Ma M; Nakagawa T; Waki H; Maeda M; Ogawa H; Kim-Mitsuyama S
Atherosclerosis; 2014 Sep; 236(1):101-7. PubMed ID: 25016364
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
Yong QC; Thomas CM; Seqqat R; Chandel N; Baker KM; Kumar R
Cardiovasc Diabetol; 2013 Nov; 12():169. PubMed ID: 24215514
[TBL] [Abstract][Full Text] [Related]
38. Are multiple angiotensin receptor types involved in angiotensin (1-7) actions on isolated rat portal vein.
Gurzu B; Costuleanu M; Slatineanu SM; Ciobanu A; Petrescu G
J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):90-5. PubMed ID: 16470488
[TBL] [Abstract][Full Text] [Related]
39. Rho-kinase contributes to hypoxia/reoxygenation-induced cerebral endothelial dysfunction.
Xie H; Ray PE; Short BL
J Cardiovasc Pharmacol; 2006 Jul; 48(1):814-9. PubMed ID: 16891909
[TBL] [Abstract][Full Text] [Related]
40. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.
Kim JH; Bugaj LJ; Oh YJ; Bivalacqua TJ; Ryoo S; Soucy KG; Santhanam L; Webb A; Camara A; Sikka G; Nyhan D; Shoukas AA; Ilies M; Christianson DW; Champion HC; Berkowitz DE
J Appl Physiol (1985); 2009 Oct; 107(4):1249-57. PubMed ID: 19661445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
